N-Ethyl-N-(piperidin-4-yl)propionamide hydrochloride, 95.0%, 1g

Titanato de estroncio-nano polvo 99,8% 50 g

4-Bromo-N-(3-chloro-2-methylphenyl)benzenesulfonamide, 95%, 5g

(3-Formyl-5-(trifluoromethyl)phenyl)boronic acid, 97%, 100mg

5H-Pyrrolo[3,4-b]pyridin-7(6H)-one, 95.0%, 100mg

(R)-5-((S)-2,2-Dimethyl-1,3-dioxolan-4-yl)-3,4-dihydroxyfuran-2(5H)-one, 95.0%, 10g

4-Ethyl-cyclohexylamine, 95.0%, 5g

3,3'-Bicarbazole>98.0%(HPLC)(N)200mg

(2E)-1-(3-bromophenyl)-3-(3-chlorophenyl)prop-2-en-1-one, 95.0%, 2g

1,2,4,5-Tetrazine, 95.0%, 100mg

2-Chloro-N,N,N-trimethylethanaminium chloride, 95.0%, 500g

Methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(trifluoromethyl)benzoate, 95.0%, 25g

Bencilamina, mínimo 99%, para síntesis, 2,5 L, envase de vidrio